247 related articles for article (PubMed ID: 18828690)
1. Novel variations and loss of heterozygosity of BRCA2 identified in a dog with mammary tumors.
Yoshikawa Y; Morimatsu M; Ochiai K; Nagano M; Tomioka Y; Sasaki N; Hashizume K; Iwanaga T
Am J Vet Res; 2008 Oct; 69(10):1323-8. PubMed ID: 18828690
[TBL] [Abstract][Full Text] [Related]
2. Single nucleotide variation in exon 11 of canine BRCA2 in healthy and cancerous mammary tissue.
Hsu WL; Huang YH; Chang TJ; Wong ML; Chang SC
Vet J; 2010 Jun; 184(3):351-6. PubMed ID: 19944633
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
Vet Pathol; 2009 May; 46(3):416-22. PubMed ID: 19176491
[TBL] [Abstract][Full Text] [Related]
4. Reduced canine BRCA2 expression levels in mammary gland tumors.
Yoshikawa Y; Morimatsu M; Ochiai K; Ishiguro-Oonuma T; Wada S; Orino K; Watanabe K
BMC Vet Res; 2015 Jul; 11():159. PubMed ID: 26202431
[TBL] [Abstract][Full Text] [Related]
5. Expression of the PTEN tumor suppressor gene in malignant mammary gland tumors of dogs.
Kanae Y; Endoh D; Yokota H; Taniyama H; Hayashi M
Am J Vet Res; 2006 Jan; 67(1):127-33. PubMed ID: 16426222
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic analysis of the BRCA2 tumor suppressor gene region in cutaneous squamous cell carcinomas.
Gray SE; Kay E; Leader M; Mabruk M
J Cutan Pathol; 2008 Jan; 35(1):1-9. PubMed ID: 18095987
[TBL] [Abstract][Full Text] [Related]
7. Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.
Lee CH; Kweon OK
J Vet Sci; 2002 Dec; 3(4):321-5. PubMed ID: 12819382
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity analysis in ductal lavage samples from BRCA1 and BRCA2 carriers: a cautionary tale.
Antill YC; Mitchell G; Johnson SA; Devereux L; Milner A; Phillips KA; Campbell IG
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1396-8. PubMed ID: 16835342
[TBL] [Abstract][Full Text] [Related]
9. Analysis of genetic variations in the exon 27 region of the canine BRCA2 locus.
Yoshikawa Y; Morimatsu M; Ochiai K; Nagano M; Yamane Y; Tomizawa N; Sasaki N; Hashizume K
J Vet Med Sci; 2005 Oct; 67(10):1013-7. PubMed ID: 16276057
[TBL] [Abstract][Full Text] [Related]
10. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.
Jonkers J; Meuwissen R; van der Gulden H; Peterse H; van der Valk M; Berns A
Nat Genet; 2001 Dec; 29(4):418-25. PubMed ID: 11694875
[TBL] [Abstract][Full Text] [Related]
11. Cloning and sequencing full length of canine Brca2 and Rad51 cDNA.
Ochiai K; Morimatsu M; Tomizawa N; Syuto B
J Vet Med Sci; 2001 Oct; 63(10):1103-8. PubMed ID: 11714026
[TBL] [Abstract][Full Text] [Related]
12. An assessment of the clonality of the components of canine mixed mammary tumours by mitochondrial DNA analysis.
Bertagnolli AC; Soares P; van Asch B; Amorim A; Cirnes L; Máximo V; Cassali GD
Vet J; 2009 Nov; 182(2):269-74. PubMed ID: 18752974
[TBL] [Abstract][Full Text] [Related]
13. Identification of tumour-associated and germ line p53 mutations in canine mammary cancer.
Veldhoen N; Watterson J; Brash M; Milner J
Br J Cancer; 1999 Oct; 81(3):409-15. PubMed ID: 10507764
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ
Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a PCR analysis method for canine BRCA2.
Yoshikawa Y; Morimatsu M; Ochiai K; Okuda K; Taoda T; Chikazawa S; Shimamura A; Omi T; Bonkobara M; Orino K; Watanabe K
BMC Res Notes; 2012 Apr; 5():173. PubMed ID: 22471976
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical assay for detecting estrogen receptors in canine mammary tumors.
Graham JC; O'Keefe DA; Gelberg HB
Am J Vet Res; 1999 May; 60(5):627-30. PubMed ID: 10328435
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability and loss of heterozygosity at the MEN1 locus in lung carcinoid tumors: a novel approach using real-time PCR with melting curve analysis in histopathologic material.
Vageli D; Daniil Z; Dahabreh J; Karagianni E; Liloglou T; Koukoulis G; Gourgoulianis K
Oncol Rep; 2006 Mar; 15(3):557-64. PubMed ID: 16465412
[TBL] [Abstract][Full Text] [Related]
18. Molecular biological aspects on canine and human mammary tumors.
Rivera P; von Euler H
Vet Pathol; 2011 Jan; 48(1):132-46. PubMed ID: 21147766
[TBL] [Abstract][Full Text] [Related]
19. Abnormal structure of the canine oncogene, related to the human c-yes-1 oncogene, in canine mammary tumor tissue.
Miyoshi N; Tateyama S; Ogawa K; Yamaguchi R; Kuroda H; Yasuda N; Shimizu T
Am J Vet Res; 1991 Dec; 52(12):2046-9. PubMed ID: 1789521
[TBL] [Abstract][Full Text] [Related]
20. Estrogens metabolism associated with polymorphisms: influence of COMT G482a genotype on age at onset of canine mammary tumors.
Dias Pereira P; Lopes CC; Matos AJ; Pinto D; Gärtner F; Lopes C; Medeiros R
Vet Pathol; 2008 Mar; 45(2):124-30. PubMed ID: 18424824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
